Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) FCF Margin (2024 - 2025)

Historic FCF Margin for Prime Medicine (PRME) over the last 2 years, with Q3 2025 value amounting to 2880.49%.

  • Prime Medicine's FCF Margin rose 101286000.0% to 2880.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 1925.63%, marking a year-over-year increase of 218639900.0%. This contributed to the annual value of 4363.36% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's FCF Margin is 2880.49%, which was up 101286000.0% from 3855.07% recorded in Q2 2025.
  • Prime Medicine's 5-year FCF Margin high stood at 662.12% for Q4 2024, and its period low was 13009.09% during Q3 2024.